Freestone Grove Partners LP Exact Sciences Corp Transaction History
Freestone Grove Partners LP
- $13.2 Trillion
- Q2 2025
A detailed history of Freestone Grove Partners LP transactions in Exact Sciences Corp stock. As of the latest transaction made, Freestone Grove Partners LP holds 214,411 shares of EXAS stock, worth $13.1 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
214,411Holding current value
$13.1 Million% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
647Shares Held
156MCall Options Held
1.43MPut Options Held
2.3M-
Capital World Investors Los Angeles, CA18.2MShares$1.12 Billion0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.9MShares$1.1 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$740 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12MShares$736 Million0.12% of portfolio
-
State Street Corp Boston, MA5.38MShares$330 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $10.8B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...